Skip to main navigation Skip to search Skip to main content

Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma

  • P. A. Thompson
  • , H. M. Prince
  • , J. F. Seymour
  • , D. Ritchie
  • , K. Stokes
  • , K. Burbury
  • , M. Wolf
  • , S. Peinert
  • , T. Joyce
  • , S. J. Harrison

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish (US)
Pages (from-to)764-765
Number of pages2
JournalBone marrow transplantation
Volume46
Issue number5
DOIs
StatePublished - May 2011

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this